Nichols William Garrett - Insider Non-Derivative Transactions at Candel Therapeutics, Inc. (CADL) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 17, 2024, Nichols William Garrett's relationship to Candel Therapeutics, Inc. (CADL) is Officer (Chief Medical Officer), and currently has 114,482 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CADL insiders.
Data Source: SEC.
Nichols William Garrett - Insider Non-Derivative Transactions of CADL Common Stock
Nichols William Garrett - Insider Non-Derivative Transactions at CADL
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jul 18, 2024 | Sell -- (Common Stock) | 10875 | 6.47 | 114482 |
| Jul 12, 2024 | Sell -- (Common Stock) | 9769 | 5.97 | 125357 |
| Nov 29, 2023 | F -- (Common Stock) | 12175 | 0.9 | 135126 |
| Nov 27, 2023 | Acquisition -- (Common Stock) | 88822 | 0 | 147301 |